Abstract
Background Human immunodeficiency virus (HIV) infection is associated with chronic pulmonary diseases, even in those with viral suppression by highly active antiretroviral treatment (HAART). Spirometry is an accurate method of diagnosing pulmonary dysfunction in people living with HIV (PLWH).
Aim To compare the prevalence of spirometric abnormalities among HAART-treated HIV patients and HAART naïve HIV patients with non-HIV controls with no recent history of pulmonary infection in a peri-urban hospital in Ghana.
Methods In a case-control design, we recruited 158 HAART-treated HIV patients, 150 HAART-naïve HIV patients and 156 non-HIV controls for the study. Clinical, sociodemographic data and respiratory symptoms were collected using a structured questionnaire. Spirometry was performed in all participants and abnormalities were categorised as obstructive (OSP) or restrictive (RSP) spirometric patterns based on the GLI definition.
Results The prevalence of OSP was similar among the HAART treated, HAART naïve HIV patients and non-HIV controls (10.1% vs 9.3% vs 9% respectively, p=0.994), whereas that of RSP was higher in HAART-treated HIV patients compared to HAART-naïve HIV patients and non-HIV controls (51.9% vs 32.1% vs 32% respectively, p=0.013). Respiratory symptoms were common among HAART-treated and HAART-naïve HIV patients compared to non-HIV controls (48.1% vs 40% vs 19.2% respectively, p<0.001). The major determinants of OSP were female gender, exposure to medium-to-high levels of biomass, presence of a respiratory symptom, unemployment and underweight, and that of RSP were age, female gender, being unmarried, medium-to-high biomass exposure and being self-employed or unemployed.
Conclusion In HIV patients without any recent pulmonary infection in a peri-urban area of Ghana, there was no difference in the prevalence of OSP among HAART-treated and HAART naïve HIV patients compared to the non-HIV control. However, the prevalence of RSP was higher in HAART-treated HIV patients compared to the other groups.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There was no funding for this study
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the College of Health Sciences’ Ethical & Protocol Review Committee (CHS-Et/M.6-5.17/2018-2019) and all participants provided written voluntary informed consent before joining the study.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The dataset supporting the conclusion of this study is available for systematic review and meta-analysis upon request from the corresponding author.
Abbreviations
- SSA
- sub-Saharan Africa
- HIV
- human immunodeficiency virus
- PLWH
- people living with HIV
- HAART
- highly active antiretroviral therapy
- FEV1
- forced expiratory volume in 1 s
- FVC
- forced vital capacity
- LLN
- lower limit of normal
- OSP
- obstructive spirometric pattern
- RSP
- restrictive spirometric patterns
- GLI
- Global Lung Initiative.